Group 1 - The report indicates that the new stock market is showing signs of recovery, with a slight increase in trading sentiment, but a complete transformation from quantity to quality is still pending [1][12][24] - The average increase of new stocks listed since 2024 is approximately 1.9%, with about 63.1% of new stocks achieving positive returns [1][27][28] - The report highlights the importance of monitoring the consensus rebuilding process in the market, suggesting that a new active cycle for new stocks is anticipated [2][12][40] Group 2 - The report notes that the issuance of new stocks is gradually returning to normal, with the average issuance price-earnings ratio for new stocks remaining low [13][18] - Recent new stocks have shown a significant disparity in performance, with some sectors like new consumption and robotics performing well, while others like military and semiconductor-related stocks have faced declines [6][28][40] - Upcoming new stocks include Weigao Blood Purification and Taili Technology, with their performance metrics indicating potential investment opportunities [3][39][40] Group 3 - The report emphasizes the need to focus on high-quality new stocks that have undergone sufficient consolidation and offer good value, particularly those benefiting from policy expectations [2][12][40] - The report suggests that the new productivity themes, such as robotics and AI, should continue to be monitored for potential investment opportunities [2][12][40] - The average issuance price-earnings ratio for new stocks set to be listed this week is 21.1X, indicating a slight decrease from previous levels [7][34]
新股休整周期尾端信号或更为清晰，变盘或只待共识重建达成